跳轉至內容
Merck
全部照片(1)

文件

SML1900

Sigma-Aldrich

Sobetirome(甲状腺激素类药物)

≥98% (HPLC)

同義詞:

2- [4-[[4-羟基-3-(1-甲基乙基)苯基]甲基] -3,5-二甲基苯氧基]乙酸, 3,5-二甲基-4-(4′-羟基-3′-异丙基苄基)苯氧乙酸, GC 1, GC-1

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C20H24O4
CAS號碼:
分子量::
328.40
分類程式碼代碼:
51111800
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: 10 mg/mL, clear

儲存溫度

−20°C

InChI

1S/C20H24O4/c1-12(2)17-9-15(5-6-19(17)21)10-18-13(3)7-16(8-14(18)4)24-11-20(22)23/h5-9,12,21H,10-11H2,1-4H3,(H,22,23)

InChI 密鑰

QNAZTOHXCZPOSA-UHFFFAOYSA-N

生化/生理作用

Sobetirome也称为2-(4-(4-苄氧基)-3-异丙基苄基)-3,5-二甲基苯氧基)乙酸/GC-1。它在生理pH下具有一个内环和带负电荷的羧酸盐基团。Sobetirome被认为可以降低人体的胆固醇水平。
Sobetirome是甲状腺激素受体(TR) β 和 TRα 的口服活性、强效激动剂,表现出选择性的组织作用。Sobetirome对心脏、骨骼和骨骼肌的无甲状腺毒性作用。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Jan Lammel Lindemann et al.
Expert opinion on therapeutic targets, 20(2), 145-149 (2015-11-14)
Sobetirome binds selectively to the main hepatic form of thyroid hormone (TH) receptor, TRβ1, compared to TRα1, which is principally responsible for thyrotoxic effects on heart, muscle and bone. Sobetirome also preferentially accumulates in liver. It was originally envisaged that
Sobetirome prodrug esters with enhanced blood?brain barrier permeability.
Placzek AT, et al.
Bioorganic & Medicinal Chemistry, 24(22), 5842-5854 (2016)
Andrew T Placzek et al.
Bioorganic & medicinal chemistry, 24(22), 5842-5854 (2016-10-26)
There is currently great interest in developing drugs that stimulate myelin repair for use in demyelinating diseases such as multiple sclerosis. Thyroid hormone plays a key role in stimulating myelination during development and also controls the expression of important genes
Ester-to-amide rearrangement of ethanolamine-derived prodrugs of sobetirome with increased blood-brain barrier penetration.
Ferrara SJ, et al.
Bioorganic & Medicinal Chemistry, 25(10), 2743-2753 (2017)
K Kannisto et al.
Atherosclerosis, 237(2), 544-554 (2014-12-03)
Thyroid hormone reduces plasma cholesterol and increases expression of low-density lipoprotein receptor (LDL-R) in liver, an effect mediated by thyroid receptor β (TRβ). The selective TRβ modulator GC-1 also enhances several steps in reverse cholesterol transport and can decrease serum

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務